Calamos Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.4M | Buy |
166,828
+3,763
| +2% | +$310K | 0.05% | 348 |
|
|
2025
Q4 | $13.9M | Sell |
163,065
-6,593
| -4% | -$541K | 0.05% | 332 |
|
|
2025
Q3 | $13.2M | Hold |
169,658
| – | – | 0.05% | 355 |
|
|
2025
Q2 | $13.3M | Hold |
169,658
| – | – | 0.05% | 350 |
|
|
2025
Q1 | $12.3M | Buy |
169,658
+1,708
| +1% | +$122K | 0.05% | 346 |
|
|
2024
Q4 | $12.4M | Buy |
167,950
+228
| +0.1% | +$16K | 0.05% | 354 |
|
|
2024
Q3 | $11.1M | Sell |
167,722
-4,099
| -2% | -$298K | 0.05% | 382 |
|
|
2024
Q2 | $15.9M | Sell |
171,821
-6,289
| -4% | -$557K | 0.07% | 297 |
|
|
2024
Q1 | $17M | Sell |
178,110
-4,463
| -2% | -$375K | 0.08% | 284 |
|
|
2023
Q4 | $13.9M | Sell |
182,573
-3,080
| -2% | -$214K | 0.07% | 316 |
|
|
2023
Q3 | $12.9M | Hold |
185,653
| – | – | 0.07% | 330 |
|
|
2023
Q2 | $17.5M | Sell |
185,653
-17
| -0% | -$1.48K | 0.09% | 284 |
|
|
2023
Q1 | $15.4M | Sell |
185,670
-29,523
| -14% | -$2.32M | 0.08% | 325 |
|
|
2022
Q4 | $16.1M | Sell |
215,193
-109,015
| -34% | -$8.4M | 0.08% | 305 |
|
|
2022
Q3 | $26.8M | Buy |
324,208
+38
| +0% | +$3.66K | 0.12% | 200 |
|
|
2022
Q2 | $30.8M | Sell |
324,170
-15,520
| -5% | -$1.61M | 0.13% | 184 |
|
|
2022
Q1 | $40M | Buy |
339,690
+31,015
| +10% | +$3.48M | 0.15% | 161 |
|
|
2021
Q4 | $40M | Sell |
308,675
-8,668
| -3% | -$1.01M | 0.15% | 158 |
|
|
2021
Q3 | $35.9M | Buy |
317,343
+26,383
| +9% | +$3.01M | 0.16% | 167 |
|
|
2021
Q2 | $30.1M | Buy |
290,960
+26,451
| +10% | +$2.49M | 0.14% | 190 |
|
|
2021
Q1 | $22.1M | Sell |
264,509
-28,458
| -10% | -$2.41M | 0.12% | 192 |
|
|
2020
Q4 | $26.7M | Buy |
292,967
+116,598
| +66% | +$9.67M | 0.16% | 171 |
|
|
2020
Q3 | $14.1M | Sell |
176,369
-8,141
| -4% | -$635K | 0.09% | 241 |
|
|
2020
Q2 | $12.8M | Sell |
184,510
-6,221
| -3% | -$442K | 0.09% | 248 |
|
|
2020
Q1 | $12M | Sell |
190,731
-84,291
| -31% | -$6.08M | 0.09% | 241 |
|
|
2019
Q4 | $21.4M | Sell |
275,022
-100,440
| -27% | -$7.84M | 0.11% | 229 |
|
|
2019
Q3 | $27.5M | Sell |
375,462
-388,437
| -51% | -$27.3M | 0.15% | 190 |
|
|
2019
Q2 | $47M | Buy |
763,899
+87,264
| +13% | +$5.28M | 0.26% | 112 |
|
|
2019
Q1 | $43.2M | Sell |
676,635
-1,293
| -0.2% | -$73.8K | 0.27% | 112 |
|
|
2018
Q4 | $34.6M | Buy |
677,928
+259,842
| +62% | +$13.1M | 0.23% | 122 |
|
|
2018
Q3 | $24.3M | Buy |
418,086
+86,967
| +26% | +$4.25M | 0.13% | 198 |
|
|
2018
Q2 | $16.1M | Buy |
331,119
+49,386
| +18% | +$2.31M | 0.1% | 255 |
|
|
2018
Q1 | $13.1M | Buy |
281,733
+162,117
| +136% | +$7.04M | 0.09% | 277 |
|
|
2017
Q4 | $4.49M | Sell |
119,616
-5,865
| -5% | -$215K | 0.02% | 409 |
|
|
2017
Q3 | $4.57M | Buy |
125,481
+3,996
| +3% | +$152K | 0.04% | 378 |
|
|
2017
Q2 | $4.79M | Buy |
121,485
+6,927
| +6% | +$253K | 0.04% | 386 |
|
|
2017
Q1 | $3.59M | Sell |
114,558
-680,343
| -86% | -$21.3M | 0.03% | 403 |
|
|
2016
Q4 | $24.8M | Sell |
794,901
-342,867
| -30% | -$11.1M | 0.2% | 150 |
|
|
2016
Q3 | $45.7M | Buy |
1,137,768
+1,052,298
| +1,231% | +$39.6M | 0.33% | 89 |
|
|
2016
Q2 | $2.84M | Sell |
85,470
-56,238
| -40% | -$1.92M | 0.02% | 410 |
|
|
2016
Q1 | $4.17M | Buy |
141,708
+8,838
| +7% | +$244K | 0.03% | 357 |
|
|
2015
Q4 | $3.5M | Hold |
132,870
| – | – | 0.02% | 385 |
|
|
2015
Q3 | $3.15M | Buy |
132,870
+48
| +0% | +$1.16K | 0.02% | 407 |
|
|
2015
Q2 | $3.15M | Sell |
132,822
-7,482
| -5% | -$169K | 0.02% | 426 |
|
|
2015
Q1 | $3.33M | Buy |
140,304
+64,914
| +86% | +$1.46M | 0.02% | 431 |
|
|
2014
Q4 | $1.6M | Buy |
75,390
+390
| +0.5% | +$7.83K | 0.01% | 505 |
|
|
2014
Q3 | $1.28M | Hold |
75,000
| – | – | 0.01% | 495 |
|
|
2014
Q2 | $1.07M | Hold |
75,000
| – | – | 0.01% | 517 |
|
|
2014
Q1 | $927K | Hold |
75,000
| – | – | 0.01% | 515 |
|
|
2013
Q4 | $822K | Hold |
75,000
| – | – | 0.01% | 524 |
|
|
2013
Q3 | $870K | Hold |
75,000
| – | – | 0.01% | 487 |
|
|
2013
Q2 | $840K | Buy |
+75,000
| New | +$888K | 0.01% | 472 |
|
Other funds holding EW
VCM
VPM
Calamos Advisors's EW Position: Q1 2026 in Review
Calamos Advisors increased its Edwards Lifesciences (EW) stake by 2.3% in Q1 2026, buying an estimated $310K and bringing the position to 166,828 shares worth $13.4M. The position accounts for 0.05% of the portfolio, ranked #348.
Calamos Advisors first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $47M in Q2 2019. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Calamos Advisors held 166,828 shares of Edwards Lifesciences worth $13.4M as of Q1 2026.
- Calamos Advisors bought 3,763 Edwards Lifesciences shares in Q1 2026, an estimated $310K.
- Edwards Lifesciences made up 0.05% of Calamos Advisors's portfolio in Q1 2026, its #348 holding.
- Calamos Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Calamos Advisors's Edwards Lifesciences position peaked at $47M in Q2 2019.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.